Literature DB >> 15464268

Possible association of mitochondrial transcription factor A (TFAM) genotype with sporadic Alzheimer disease.

Claudia Günther1, Kirsten von Hadeln, Tomas Müller-Thomsen, Antonella Alberici, Giuliano Binetti, Christoph Hock, Roger M Nitsch, Gabriela Stoppe, Jochen Reiss, Andreas Gal, Ulrich Finckh.   

Abstract

Mitochondrial transcription factor A (TFAM) is essential for transcription and replication of mammalian mitochondrial DNA (mtDNA). Disturbance of maintenance of mtDNA integrity or mitochondrial function may underlay neurodegenerative disorders such as Alzheimer disease (AD). TFAM, the gene encoding TFAM maps to chromosome 10q21.1, a region that showed linkage to late-onset AD in several study samples. We screened TFAM for single nucleotide polymorphisms (SNPs) and genotyped the G>C SNP rs1937, coding for S12T in mitochondrial signal sequence of TFAM, and the A>G SNP rs2306604 (IVS4+113A>G) in 372 AD patients and 295 nondemented control subjects. There was an association of genotype rs1937G/G with AD in females and an association of a TFAM haplotype with AD both in the whole sample and in females. The findings suggest that a TFAM haplotype containing rs1937 G (for S12) may be a moderate risk factor for AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464268     DOI: 10.1016/j.neulet.2004.07.070

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  19 in total

1.  Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.

Authors:  Baiyang Sheng; Xinglong Wang; Bo Su; Hyoung-gon Lee; Gemma Casadesus; George Perry; Xiongwei Zhu
Journal:  J Neurochem       Date:  2011-12-08       Impact factor: 5.372

Review 2.  The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  Biochim Biophys Acta       Date:  2013-09-23

Review 3.  The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms.

Authors:  Inhae Kang; Charleen T Chu; Brett A Kaufman
Journal:  FEBS Lett       Date:  2018-02-15       Impact factor: 4.124

Review 4.  Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer's disease.

Authors:  Russell H Swerdlow
Journal:  Antioxid Redox Signal       Date:  2011-09-15       Impact factor: 8.401

Review 5.  Genetic aspects of Alzheimer disease.

Authors:  Jennifer Williamson; Jill Goldman; Karen S Marder
Journal:  Neurologist       Date:  2009-03       Impact factor: 1.398

Review 6.  The Alzheimer's disease mitochondrial cascade hypothesis: an update.

Authors:  Russell H Swerdlow; Shaharyar M Khan
Journal:  Exp Neurol       Date:  2009-01-29       Impact factor: 5.330

7.  Vitamin D Receptor (VDR) Polymorphisms and Late-Onset Alzheimer's Disease: An Association Study.

Authors:  Hamid Reza Khorram Khorshid; Elnaz Gozalpour; Kioomars Saliminejad; Masood Karimloo; Mina Ohadi; Koorosh Kamali
Journal:  Iran J Public Health       Date:  2013-11       Impact factor: 1.429

8.  HAP1 can sequester a subset of TBP in cytoplasmic inclusions via specific interaction with the conserved TBP(CORE).

Authors:  Justin R Prigge; Edward E Schmidt
Journal:  BMC Mol Biol       Date:  2007-09-14       Impact factor: 2.946

9.  Analysis of mitochondrial transcription factor A SNPs in alcoholic cirrhosis.

Authors:  Chun Tang; Hongming Liu; Yongliang Tang; Yong Guo; Xianchun Liang; Liping Guo; Ruxian Pi; Juntao Yang
Journal:  Exp Ther Med       Date:  2013-10-21       Impact factor: 2.447

10.  The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson's disease.

Authors:  Katarzyna Gaweda-Walerych; Cezary Zekanowski
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.